3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Urogenital Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Ovarian Cysts
1
Neoplasms
1
Gonadal Disorders
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Disease
1
Cysts
1
Adnexal Diseases
1
Interventions
anlotinib
2
tislelizumab
1
onapristone
1
olaparib
1
niraparib
1
abiraterone
1
Technetium Tc 99m Medronate
1
Pluvicto
1
Nivolumab
1
Manual Lymphatic Drainage
1
Ipilimumab
1
Gemcitabine
1
Gamma Cameras
1
Dosage Forms
1
Diffusion
1
Cisplatin
1
Carboplatin
1
Biopsy, Needle
1
Bevacizumab
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Urogenital Neoplasms
×
Diffusion
×
Clear all
NCT02836275
2020-04-14
IOTA-MRI
KU Leuven
Phase NA
Unknown
250 enrolled